Deyao B. Wu

300 Guangzhou Road
Nanjing, 210029, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Correction to: miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS.

Correction to: miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS.

Journal: Molecular and cellular biochemistry

Published: June 23, 2025

microRNA-125b inhibits cell migration and invasion by targeting matrix metallopeptidase 13 in bladder cancer.

microRNA-125b inhibits cell migration and invasion by targeting matrix metallopeptidase 13 in bladder cancer.

Journal: Oncology letters

Published: October 24, 2022

Long noncoding RNA NNT-AS1 enhances the malignant phenotype of bladder cancer by acting as a competing endogenous RNA on microRNA-496 thereby increasing HMGB1 expression.

Long noncoding RNA NNT-AS1 enhances the malignant phenotype of bladder cancer by acting as a competing endogenous RNA on microRNA-496 thereby increasing HMGB1 expression.

Journal: Aging

Published: September 20, 2019

Clear Cell Renal Cell Carcinoma With Extensive Osseous Metaplasia: Report of a Rare Case.

Clear Cell Renal Cell Carcinoma With Extensive Osseous Metaplasia: Report of a Rare Case.

Journal: Urology

Published: February 17, 2017

[Corrigendum] MicroRNA‑379‑5p plays a tumor‑suppressive role in human bladder cancer growth and metastasis by directly targeting MDM2.

[Corrigendum] MicroRNA‑379‑5p plays a tumor‑suppressive role in human bladder cancer growth and metastasis by directly targeting MDM2.

Journal: Oncology reports

Published: October 08, 2016

MicroRNA-379-5p plays a tumor-suppressive role in human bladder cancer growth and metastasis by directly targeting MDM2.

MicroRNA-379-5p plays a tumor-suppressive role in human bladder cancer growth and metastasis by directly targeting MDM2.

Journal: Oncology reports

Published: October 08, 2016

MicroRNA-335 is downregulated in bladder cancer and inhibits cell growth, migration and invasion via targeting ROCK1.

MicroRNA-335 is downregulated in bladder cancer and inhibits cell growth, migration and invasion via targeting ROCK1.

Journal: Molecular medicine reports

Published: May 04, 2015

[Corrigendum] MicroRNA‑335 is downregulated in bladder cancer and inhibits cell growth, migration and invasion via targeting ROCK1.

[Corrigendum] MicroRNA‑335 is downregulated in bladder cancer and inhibits cell growth, migration and invasion via targeting ROCK1.

Journal: Molecular medicine reports

Published: May 04, 2015

Novel somatic mutations identified by whole-exome sequencing in muscle-invasive transitional cell carcinoma of the bladder.

Novel somatic mutations identified by whole-exome sequencing in muscle-invasive transitional cell carcinoma of the bladder.

Journal: Oncology letters

Published: December 25, 2014

Tumor-suppressing effects of microRNA-429 in human renal cell carcinoma via the downregulation of Sp1.

Tumor-suppressing effects of microRNA-429 in human renal cell carcinoma via the downregulation of Sp1.

Journal: Oncology letters

Published: December 22, 2014

MicroRNA-497 targets hepatoma-derived growth factor and suppresses human prostate cancer cell motility.

MicroRNA-497 targets hepatoma-derived growth factor and suppresses human prostate cancer cell motility.

Journal: Molecular medicine reports

Published: December 16, 2014

Upregulation of microRNA-204 inhibits cell proliferation, migration and invasion in human renal cell carcinoma cells by downregulating SOX4.

Upregulation of microRNA-204 inhibits cell proliferation, migration and invasion in human renal cell carcinoma cells by downregulating SOX4.

Journal: Molecular medicine reports

Published: November 11, 2014

Showing 1-12 of 24

Last Updated: 09/26/2026